Siegfried Evionnaz SA

Siegfried is active in both the primary and secondary production of drugs. The group operates production facilities in Switzerland, Germany, France, Malta, China and the USA and develops and produces active pharmaceutical ingredients (API) and intermediates for the research-based pharmaceutical industry as well as controlled substances and formulated drug products. In addition, it offers development and manufacturing services for finished dosage forms, including sterile filling.
Our Vision: To be a world-class partner in developing and manufacturing drugs that improve human life. Evionnaz main activities: Pilot and commercial manufacturing of drug substances (APIs) and related intermediates – All fully cGMP and SHE compliant. Highly specialized in niche technologies. Development capacities range from gram to industrial quantities.